Benzinga | Dec 21, 2021 02:53PM EST

'CRISPR Therapeutics could set a milestone by filing for approval before the end of 2022 with its sickle cell/beta thal treatment...' -Tweet From Business Insider Pharma Reporter

https://twitter.com/AndrewE_Dunn/status/1473380281818443777